CKB News Archive



  • 2019
    • October
      • Have a question about CKB or want to learn more about it? Then check out The Scoop on CKB!
      • Are you attending AMP 2019 next week? If so, visit the JAX booth #3016 for a live demo of CKB!
  • 2019
    • July
      • CKB BOOST now has AMP/CAP/ASCO evidence level coding!
  • 2019
    • June
      • CKB CORE brings back EGFR, PIK3CA, removes BRCA1, BRCA2, KRAS, and offers new content with DDR2.
  • 2018
    • November
      • Vitrakvi (larotrectinib) approved regardless of tumor type for NTRK fusions, except with acquired resistance mutations! Need a list of resistance mutations? Visit ckbhome.jax.org and sign-up for CKB BOOST.
  • 2017
    • October
      • Barriers preventing the adoption of comprehensive cancer genomic profiling in the clinic (PMID: 28402162). Limited free copies available; request your copy at ckbsupport@jax.org.